Opus Genetics (IRD) Amortizatization of Intangibles (2018 - 2020)
Opus Genetics' (IRD) quarterly Amortizatization of Intangibles came in at -$1000.0 in Q4 2020, down 100.11% year-on-year from $927230.0 in Q1 2020, and down 112.5% on a QoQ basis from $8000.0 in Q3 2020.
Opus Genetics (IRD) Amortizatization of Intangibles (2018 - 2020) Analysis & Trends
Opus Genetics (IRD) has 3 years of Amortizatization of Intangibles data on file, last reported at -$1000.0 in Q4 2020.
- On a quarterly basis, Amortizatization of Intangibles fell 100.11% year-over-year to -$1000.0 in Q4 2020; TTM through Sep 2021 was -$1000.0, a 100.06% decrease from a year earlier, with the FY2020 full-year figure at $873000.0, down 13.91% from the prior year.
- Amortizatization of Intangibles for Q4 2020 stood at -$1000.0, down from $8000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for IRD reached as high as $927230.0 in Q4 2019 and fell as low as -$14907.0 in Q1 2018.
- Historically, Amortizatization of Intangibles has averaged $154812.4 across 3 years, with a median of $13249.5 in 2019.
- Across the five-year window, Amortizatization of Intangibles soared 22491.45% in 2019 and plunged 100.11% in 2020, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$4141.0 in 2018, then soared by 22491.45% to $927230.0 in 2019, then plunged by 100.11% to -$1000.0 in 2020.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were -$1000.0 in Q4 2020, $8000.0 in Q3 2020, and $500000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 376,000.00 |
| Mar 31, 2020 | 376,000.00 |
| Dec 31, 2019 | 927,230.00 |
| Dec 31, 2019 | 927,230.00 |
| Sep 30, 2019 | 30,751.00 |
| Sep 30, 2019 | 30,751.00 |
| Jun 30, 2019 | 37,520.00 |
| Jun 30, 2019 | 37,520.00 |
| Mar 31, 2019 | 18,499.00 |
| Mar 31, 2019 | 18,499.00 |
| Dec 31, 2018 | -4,141.00 |
| Dec 31, 2018 | -4,141.00 |
| Sep 30, 2018 | -8,606.00 |
| Sep 30, 2018 | -8,606.00 |